Issue 3/2012
Content (39 Articles)
ADAM12 induces estrogen-independence in breast cancer cells
Roopali Roy, Marsha A. Moses
Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas
Rozina Tufail, Mercy Jorda, Wei Zhao, Isildinha Reis, Zafar Nawaz
Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers
Alessandra Estrela-Lima, Márcio Sobreira Silva Araújo, João Moreira da Costa-Neto, Lorena Gabriela Rocha Ribeiro, Karine Araújo Damasceno, Mário Jorge Melhor Heine D’Assis, Olindo Assis Martins-Filho, Andréa Teixeira-Carvalho, Rogéria Serakides, Geovanni Dantas Cassali
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
Pascal Jézéquel, Mario Campone, Wilfried Gouraud, Catherine Guérin-Charbonnel, Christophe Leux, Gabriel Ricolleau, Loïc Campion
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells
Yi Huang, Shauna N. Vasilatos, Lamia Boric, Patrick G. Shaw, Nancy E. Davidson
LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis
Zhi-Yu Wang, Tjing Yung Loo, Jian-Gang Shen, Neng Wang, Dong-Mei Wang, De-Po Yang, Sui-Lin Mo, Xin-Yuan Guan, Jian-Ping Chen
Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast
Malgorzata Banys, Ines Gruber, Natalia Krawczyk, Sven Becker, Ralph Kurth, Diethelm Wallwiener, Jolanta Jakubowska, Jürgen Hoffmann, Ralf Rothmund, Annette Staebler, Tanja Fehm
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs
Ernst-Jan Geutjes, Sun Tian, Paul Roepman, René Bernards
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?
Viviana Galimberti, Edoardo Botteri, Camelia Chifu, Oreste Gentilini, Alberto Luini, Mattia Intra, Paola Baratella, Manuela Sargenti, Stefano Zurrida, Paolo Veronesi, Nicole Rotmensz, Giuseppe Viale, Angelica Sonzogni, Marco Colleoni, Umberto Veronesi
Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics
E. H. Lips, L. Mulder, J. J. de Ronde, I. A. M. Mandjes, A. Vincent, M. T. F. D. Vrancken Peeters, P. M. Nederlof, J. Wesseling, S. Rodenhuis
The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer
Ji-Yu Li, Zhou-Luo Ou, San-Jian Yu, Xiao-Li Gu, Chen Yang, Ao-Xiang Chen, Gen-Hong Di, Zhen-Zhou Shen, Zhi-Ming Shao
Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer
Min Han Tan, Sarmishtha De, Gurkan Bebek, Mohammed S. Orloff, Robert Wesolowski, Erinn Downs-Kelly, G. Thomas Budd, George R. Stark, Charis Eng
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer
Anneke Q. van Hoesel, Cornelis J. H. van de Velde, Peter J. K. Kuppen, Hein Putter, Esther M. de Kruijf, Johanna G. H. van Nes, Armando E. Giuliano, Dave S. B. Hoon
A signature of immune function genes associated with recurrence-free survival in breast cancer patients
Maria Libera Ascierto, Maciej Kmieciak, Michael O. Idowu, Rose Manjili, Yingdong Zhao, Margaret Grimes, Catherine Dumur, Ena Wang, Viswanathan Ramakrishnan, Xiang-Yang Wang, Harry D. Bear, Francesco M. Marincola, Masoud H. Manjili
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Rutika J. Mehta, Rohit K. Jain, Samuel Leung, Jennifer Choo, Torsten Nielsen, David Huntsman, Harikrishna Nakshatri, Sunil Badve
Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway
Tao Li, Zhiguo Feng, Shaohui Jia, Wei Wang, Zhongxia Du, Ning Chen, Zhengwang Chen
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer
G. Somlo, C. L. Martel, S. K. Lau, P. Frankel, C. Ruel, L. Gu, A. Hurria, C. Chung, T. Luu, R. Morgan Jr, L. Leong, M. Koczywas, M. McNamara, C. A. Russell, S. E. Kane
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer
Aditya Bardia, Erin T. Arieas, Zhe Zhang, Andrew DeFilippis, Karineh Tarpinian, Stacie Jeter, Anne Nguyen, N. Lynn Henry, David A. Flockhart, Daniel F. Hayes, Jill Hayden, Anna Maria Storniolo, Deborah K. Armstrong, Nancy E. Davidson, John Fetting, Pamela Ouyang, Antonio C. Wolff, Roger S. Blumenthal, M. Dominique Ashen, Vered Stearns
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer
Michaela J. Higgins, Tatiana M. Prowell, Amanda L. Blackford, Celia Byrne, Nagi F. Khouri, Shannon A. Slater, Stacie C. Jeter, Deborah K. Armstrong, Nancy E. Davidson, Leisha A. Emens, John H. Fetting, Pendleton P. Powers, Antonio C. Wolff, Hannah Green, Jacklyn N. Thibert, James M. Rae, Elizabeth Folkerd, Mitchell Dowsett, Roger S. Blumenthal, Judy E. Garber, Vered Stearns
Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle
R. Wolters, L. Schwentner, A. Regierer, M. Wischnewsky, R. Kreienberg, A. Wöckel
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M. Gartner, Paula Silverman, Michael Simon, Lawrence Flaherty, Judith Abrams, Percy Ivy, Patricia M. LoRusso
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
T. Hatschek, L. Carlsson, Z. Einbeigi, E. Lidbrink, B. Linderholm, B. Lindh, N. Loman, M. Malmberg, S. Rotstein, M. Söderberg, M. Sundquist, T. M. Walz, M. Hellström, H. Svensson, G. Åström, Y. Brandberg, J. Carstensen, M. Fernö, J. Bergh
Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991
Robert C. Burton, Robin J. Bell, Geetha Thiagarajah, Christopher Stevenson
Trajectories of body image and sexuality during the first year following diagnosis of breast cancer and their relationship to 6 years psychosocial outcomes
Wendy W. T. Lam, Wylie W. Y. Li, George A. Bonanno, Anthony D. Mancini, Miranda Chan, Amy Or, Richard Fielding
Breast tenderness after initiation of conjugated equine estrogens and mammographic density change
Carolyn J. Crandall, Aaron K. Aragaki, Jane A. Cauley, Anne McTiernan, JoAnn E. Manson, Garnet L. Anderson, Jean Wactawski-Wende, Rowan T. Chlebowski
Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers
Shiri Bernholtz, Ariella Jakobson-Setton, Jacob Korach, Gilad Ben Baruch, Yael Laitman, Eitan Friedman
Incidence and risk factors for axillary web syndrome after breast cancer surgery
Anke Bergmann, Valéria Vasconcellos Mendes, Ricardo de Almeida Dias, Blenda do Amaral e Silva, Maria Giseli da Costa Leite Ferreira, Erica Alves Nogueira Fabro
Alcohol intake and mammographic density in postmenopausal Norwegian women
Samera Azeem Qureshi, Elisabeth Couto, Solveig Hofvind, Anna H. Wu, Giske Ursin
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression
Xuezheng Sun, Patricia Casbas-Hernandez, Carol Bigelow, Liza Makowski, D. Joseph Jerry, Sallie Smith Schneider, Melissa A. Troester
Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008
Lotte Holm Land, Susanne Oksbjerg Dalton, Maj-Britt Jensen, Marianne Ewertz
Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER
Gila Neta, William F. Anderson, Ethel Gilbert, Amy Berrington
Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting
Emily K. Tam, Ling Shen, Julie R. Munneke, Lynn M. Ackerson, Paula N. Partee, Carol P. Somkin, Mary André, Susan E. Kutner, Saskia R. J. Thiadens, Marilyn L. Kwan
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer
Hong Shi, Melanie Bevier, Robert Johansson, Kerstin Enquist-Olsson, Roger Henriksson, Kari Hemminki, Per Lenner, Asta Försti
High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas
Aglaya G. Iyevleva, Ekatherina Sh. Kuligina, Nathalia V. Mitiushkina, Alexandr V. Togo, Yoshio Miki, Evgeny N. Imyanitov
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L. C. Collins, J. D. Marotti, S. Gelber, K. Cole, K. Ruddy, S. Kereakoglow, E. F. Brachtel, L. Schapira, S. E. Come, E. P. Winer, A. H. Partridge
Prediction of menopausal status from estrogen-related gene expression in benign breast tissue
Oukseub Lee, Irene B. Helenowski, Robert T. Chatterton Jr, Borko Jovanovic, Seema A. Khan
Parity and mortality from causes other than breast cancer in breast cancer patients
Mai Kadi, Petra A. Wark, Marc J. Gunter, Elio Riboli
Erratum to: Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis
Theodoros N. Sergentanis, Konstantinos P. Economopoulos
Erratum to: Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis
Sirkku Pollari, Sanna-Maria Käkönen, Henrik Edgren, Maija Wolf, Pekka Kohonen, Henri Sara, Theresa Guise, Matthias Nees, Olli Kallioniemi